Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Trial Shows Treatment Desensitizes Peanut Allergies

A large-scale clinical trial shows a preventive treatment desensitizes peanut allergies in children, with most participants able to tolerate substantial amounts of peanut proteins after 1 year. . . . → Read More: Trial Shows Treatment Desensitizes Peanut Allergies

Patents Awarded for Genetic Editing of CAR T-Cells

U.S. patents were awarded to a biotechnology company developing therapies using the genomic editing process known as Crispr to create immune system cells with proteins for attacking cancer cells. . . . → Read More: Patents Awarded for Genetic Editing of CAR T-Cells

Neuro Therapy Company Spins-Off, Gains $20.8M Funding

A company developing treatments for cognitive impairment and Alzheimer’s disease is starting-up in Belgium, with a technology and financial backing from local and global businesses and investors. . . . → Read More: Neuro Therapy Company Spins-Off, Gains $20.8M Funding

Open-Source Discovery Seeks Neglected Disease Drug

An international online collaboration is using an open process to discover new drug compounds to treat mycetoma, a slow-progressing inflammatory fungal disease occurring mainly in developing regions, which up to now is largely neglected. . . . → Read More: Open-Source Discovery Seeks Neglected Disease Drug

FDA Approves Wearable Epilepsy Seizure Detector

The U.S. Food and Drug Administration approved a device worn like a wristwatch that uses a machine-learning algorithm to detect convulsive seizures in people with epilepsy. . . . → Read More: FDA Approves Wearable Epilepsy Seizure Detector

Brain Wave Data Harnessed for Open-Source Brain Model

A lab in Germany created a technique for discovering a person’s neurological patterns from brain waves captured with a headset and simulated with population-wide brain data run on open-source software. . . . → Read More: Brain Wave Data Harnessed for Open-Source Brain Model

Sanofi Buys Nano-Antibody Biotech in $4.8B Deal

Global drug maker Sanofi is acquiring a Belgian biotechnology company developing synthetic nanoscale therapeutic antibodies in a deal valued at $4.8 billion. . . . → Read More: Sanofi Buys Nano-Antibody Biotech in $4.8B Deal

Nerve Stimulation Shown to Treat Cluster Headaches

A device that stimulates a collection of nerves located behind the nose was shown in a year-long study to lower intensity and frequency of cluster headaches, a condition marked by repeating episodes of severe pain. . . . → Read More: Nerve Stimulation Shown to Treat Cluster Headaches

Institute Using Software to Boost Results Reproducibility

A genomics research lab in the U.K. is adding software to automate data collection that its developer says can improve the productivity of scientists and reproducibility of their findings. . . . → Read More: Institute Using Software to Boost Results Reproducibility

Blood Disorder Drug Maker Acquired in $11.6B Deal

The global pharmaceutical company Sanofi is buying Bioverativ Inc., a developer of biologics to treat hemophilia and other rare blood disorders. . . . → Read More: Blood Disorder Drug Maker Acquired in $11.6B Deal